NASDAQ
FluoroPharma Medical, Inc. (FPMI) has a free cash flow growth of 78.07% as of Friday, May 29, 2026. This represents a 232.27% increase compared to its 12-month average of -59.02%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.